DeepCyte

About DeepCyte

DeepCyte specializes in predicting and explaining drug toxicity at the single-cell level by combining single-cell metabolomics with AI-driven models. The company aims to reveal why cells become toxic before drugs reach patients, enabling safer and more affordable therapeutics. Operating with a presence in the United States (Delaware) and Denmark (Copenhagen), DeepCyte offers mechanistic insights into how drugs rewire cellular metabolism and cause toxicity, going beyond traditional risk scores.